Pharmaceutical companies will accelerate adoption of adaptive clinical trial designs, according to the Tufts Center for Drug Development, to reduce clinical development timelines and costs while ...

Pharmaceutical companies strive to simultaneously manage four 'levers' to increase the value of clinical-stage programmes: risk (including technical, regulatory and commercial risks), cost, revenues ...

Great design is rooted in responsive and adaptive approaches. For architect and landscape architect Greg Kochanowski, equitable design solutions should address critical issues, such as climate and ...

The primary goal of the trial was to optimize radiation therapy (RT) dose among three levels (low, standard, and high), given either with placebo (P) or an investigational agent (A), for treating ...